The study investigates the effects of combining intermediate alcohol consumption with a Western diet to create a mouse model (DUAL) that simulates both alcohol-associated and metabolic fatty liver diseases.
Mice on the DUAL diet showed significant weight gain, liver damage, and signs of metabolic distress, including increased fat cell size, high cholesterol, and high blood sugar levels.
The findings suggest that this DUAL model closely resembles human advanced steatohepatitis, making it a useful preclinical tool for finding new treatments.